Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Preventive Medicine|September 1, 1993
Oral cancer prevention: the case for carotenoids and anti-oxidant nutrientsH Garewal, F Meyskens, S Friedman, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1995
Risk factors for Barrett's oesophagus: a life history approach to behavioural assessment in the distant pastC Ritenbaugh, R Sampliner, M Aickin, et al.Mutation Research|January 18, 2005
Bile acids as carcinogens in human gastrointestinal cancersH Bernstein, C Bernstein, C M Payne, et al.Antioxidants & Redox Signaling|January 5, 2002
The specific NOS2 inhibitor, 1400W, sensitizes HepG2 cells to genotoxic, oxidative, xenobiotic, and endoplasmic reticulum stressesC M Payne, H Bernstein, C Bernstein, et al.Antioxidants & Redox Signaling|March 10, 2001
Reactive nitrogen species in colon carcinogenesisC M Payne, C Bernstein, H Bernstein, et al.The American Journal of Gastroenterology|October 16, 1999
Biomarker studies in reversed Barrett's esophagusH Garewal, L Ramsey, P Sharma, et al.Digestive Diseases and Sciences|September 1, 1990
Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagusH Garewal, P Meltzer, J Trent, et al.Journal of the National Cancer Institute|November 21, 1990
Prospective study of the frequency and size distribution of polyps missed by colonoscopyL J Hixson, M B Fennerty, R E Sampliner, et al.The American Journal of Gastroenterology|November 15, 1997
Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epitheliumA Grade, G Pulliam, C Johnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1984
Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disordersH Garewal, B G Durie, R A Kyle, et al.Pageof 4